In vitro activity of oral ß-lactams against 40 ß-lactamase producing strains of Branhamella (Moraxella) catarrhalis correlated to the inoculum size;Activit́ in vitro de ß-lactamines orales sur quarante souches de Branhamella (Moraxella) catarrhalis productrices de ß-lactamase en fonction de la taille de 1'inoculum

Medecine et Maladies Infectieuses

Volumn 27, Issue 9 AUG, 1997, Pages 774-777

  Roques, Ch ^a   Roux, I ^a   Hbabi, L ^a   Federlin, M ^b   Michel, G ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Amoxicillin elavulanate; Branhamella (Moraxella) catarrhalis; Cephalosporins; Penicillins; lactamase

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFPODOXIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; PENICILLIN DERIVATIVE; SULBACTAM;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DILUTION; IN VITRO STUDY; MORAXELLA CATARRHALIS; NONHUMAN;

EID: 0030819381     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-077x(97)80153-9     Document Type: Article

References (17)

1. KOVATCH A.L., WALD E.R., MICHAELS R.H. - Beta-lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr. 1983; 102 : 261-4.
2. ALVAREZ S., JONES M., HOLSTCLAW-BERK S., GUARDERAS J., BERK S. - In vitro susceptibilities and ß-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother. 1985; 27 : 646-7.
3. DOERN G.V. - Branhamella catarrhalis - an emerging human pathogen. Diagn Microbiol Infect Dis. 1986 ; 4; 191-201.
4. BLUESTONE C.D. - Modem management of otitis media. Fed Clin North Amer. 1988; 36 : 6-10.
5. GEHANNO P. - Epidémiologie bactérienne et analyse critique des essais thérapeutiques dans l'otite. Méd Mal Infect. 1992; 22 : 114-29.
6. SCOTT GIEBINK G. - The microbiology of otitis media. Pediatr Infect Dis J. 1989; 8: S18-20.
7. GEHANNO P., BOUCOT I., SIMONET M., BINGEN E., LAMBERT ZECHOVSKY N., BERCHE P. - Epidémiologie bactérienne de l'otite aiguë chez l'enfant, en région parisienne, de 1987 à 1991, à propos de 1232 cas. Lettre Infectiol. 1992; 13 : 408-14.
8. SHURIN P.A., MARCHANT C.D., KIM C.H., VAN HARE G.F., JOHNSON C.E., TUTIHASI M.A., KNAPP L.J. - Emergence of beta-lactamase-producing strains of Branhamella catarrhalis important agents of acute otitis media. Pediatr Infect Dis. 1983; 2 : 34-8.
9. BLUESTONE C.D. - Management of otitis media in infants and children: current role of old and new antimicrobial agents. Pediatr Infect Dis J. 1988; 7: S129-S36.
10. DOERN G.V., SIEBERS K.G., HALLICK I.M., MORSE S.A. - Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother. 1980; 17 : 24-9.
11. WALLACE R.J., STEINGRUBE V.A., NASH D.R., HOLLIS D.G., FLANAGAN C., BROWN B.A., LABIDI A., WEAVER R.E. - BRO ß-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal ß-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrob Agents Chemother. 1989; 33 : 1845-54.
12. STEINGRUBE V.A., WALLACE R.J., BEAULIEU D. - A membrane-bound precursor ß-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 ß-lactamases. J Antimicrob Chemother. 1993; 31 : 237-44.
13. PERCIVAL A., CORKILL J.E., ROLANDS J., SYKES R.B. - Pathogenicity of and ß-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet. 1977; 2 : 1175-9.
14. BROOK I. - Clinical implications of the inoculum effect with ß-lactam antibiotics. Inf Med. 1990; 7-19.
15. WALD E.R., ROHN D.D., CHIPONIS D.M., BLATTER M.M., REISINGER K.S., WUCHER P.P. - Quantitative cultures of middle-ear fluid in acute otitis media. J Pediatr. 1983; 102 : 259-61.
16. DOERN G.V., MORSE S.A. - Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J Clin Microbiol. 1980; 11 : 193-5.
17. KRAUSE P.J., OWENS N.J., NIGHTINGALE C.H., KLIMEK J.J., LEHMANN W.B., QUINTILIANI R. - Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into middle-ear fluid of patients with chronic serous otitis media. J Infect Dis. 1982; 45 : 815-21.